Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology

International Journal of Hyperthermia

Volumn 12, Issue 1, 1996, Pages 3-20

  Overgaard, J ^a   Gonzalez Gonzalez, D ^b   Hulshof, M C C H ^b   Arcangeli, G ^c   Dahl, O ^d   Mella, O ^d   Bentzen, S M ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c G Porfiri Oncology Centre   (Italy)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Hyperthermia; Local control; Malignant melanoma; Quality assurance; Radiotherapy; Randomized multicentre trial; Survival; Thermometry

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HEATING; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; PROGNOSIS; RADIATION DOSE; REGRESSION ANALYSIS; TIME; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0029980499     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609023685     Document Type: Article

References (39)

1. ARCANGELI, G., BENASSI, M., CIVIDALLI, A., LOVISOLO, G. A., and MAURO, F., 1987. Radiotherapy and hyperthermia. Analysis of clinical results and identification of prognostic variables. Cancer, 60, 950-956.
2. ARCANGELI, G., OVERGAARD, J., GONZALEZ GONZALEZ, D., and SHRIVASTAVA, P. M., 1988, Hyperthermia trials. International Journal of Radiation Oncology, Biology, and Physics, 14, S93-S109.
3. BEN-YOSEF, R., and KAPP, D. S., 1993. Prognostic factors in metastatic malignant melanoma treated with combined radiation therapy and hyperthermia. International Journal of Hyperthermia. 9, 767-781.
4. BENTZEN, S. M., OVERGAARD, J., THAMES, H. D., OVERGAARD, M., HANSEN, P. V., VON DER MAASE, H., and MEDER, J., 1989. Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology, 16, 169-182.
5. Cox, R. S., and KAPP, D. S., 1992, Correlation of thermal parameters with outcome in combined radiation therapy-hyperthermia trials. International Journal of Hyperthermia, 8, 719-732.
6. CURRAN, W. J., and GOODMAN, R. L., 1992, Hyperthermia 1991: A critical review. Radiation Research: a Twentieth-Century Perspective, edited by W. C. Dewey, M. Edington, R. J. Fry, E. J. Hall and G. F Whitmore (San Diego: Academic), pp. 883-888.
7. DEWEY, W. C., 1994, Arrhenius relationships from the molecule and cell to the clinic. International Journal of Hyperthermia, 10, 457-483.
8. DEWHIRST, M. W., GRIFFIN, T. W., SMITH, A. R., PARKER, R. G., HANKS, G. E., and BRADY, L. W., 1993, Intersociety council on radiation oncology essay on the introduction of new medical treatments into practice. Journal of the National Cancer Institute, 85, 951-957.
9. EMAMI, B., PEREZ, C. A., KONEFAL, J., PILEPICH, M. V., LEYBOVICH, L., STRAUBE, W., VONGERICHTEN, D., and HEDERMAN M. A., 1988, Thermoradiotherapy of malignant melanoma. International Journal of Hyperthermia, 4, 373-381.
10. ENGIN, K., TUPCHONG, L., PHIL, D., WATERMAN, F. M., MOYLAN, D. J., NERLINGER, R. E., and LEEPER, D. B., 1992, Hyperthermia and radiation in advanced malignant melanoma. International Journal of Radiation Oncology, Biology, and Physics, 25, 87-94.
11. FIELD, S. B., and MORRIS, C. C., 1983, The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiotherapy and Oncology, 1, 179-186.
12. GONZALEZ GONZALEZ, D., VAN DIJK, J. D. P., BLANK, L. E. C. M., and RUM̈KE, P., 1986, Combined treatment with radiation and hyperthermia in metastatic malignant melanoma. Radiotherapy and Oncology, 6, 105-113.
13. HAND, J. W., LAGENDIJK, J. J. W., BACH ANDERSEN, J., and BOLOMEY, J. C., 1989, Quality assurance guidelines for ESHO protocols. International Journal of Hyperthermia, 5, 421-428.
14. HOFMAN, P., KNOL, R. G. F., LAGENDIJK, J. J. W., and SCHIPPER, J., 1989, Thermoradiotherapy of primary breast carcinoma. International Journal of Hyperthermia, 5, 1-12.
15. ICRU REPORT 29, 1978, Dose specification for reporting external beam therapy with photons and electrons, International Commission on Radiation Units and Measurements, Bethesda, Maryland, USA.
16. INTERNATIONAL COLLABORATIVE HYPERTHERMIA GROUP, 1995, Hyperthermia in the treatment of superficial localized primary and recurrent breast cancer - results from five randomized controlled trials. International Journal of Radiation Oncology, Biology, and Physics, (submitted).
17. KAPP, D. S., 1986, Site and disease selection for hyperthermic clinical trials. International Journal of Hyperthermia, 2, 139-156.
18. KIM, J. H., HAHN, E. W., and AHMED, S. A., 1982, Combination hyperthermia and radiation therapy for malignant melanoma. Cancer, 50, 478-482.
19. MEYER, J. L., KAPP, D. S., FESSENDEN, P., and HAHN, G. H., 1989, Hyperthermic oncology: current biolosy, physics and clinical results. Pharmacology and Therapeutics, 42, 251-288.
20. MILLER, A. B., HOOGSTRATEN, B., STAQUET, M., and WINKLER, A., 1981, Reporting results of cancer treatment. Cancer, 47, 207-214.
21. MULLER, C., 1910, Eine neue Behandlungsmethode bösartiger Geschwülste. Münchener Medizinische Wochenschrift, 28, 1490-1493.
22. OVERGAARD, J., 1981, Fractionated radiation and hyperthermia. Experimental and clinical studies. Cancer, 48, 1116-1123.
23. OVERGAARD, J., 1986, The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. International Journal of Radiation Oncology, Biology, and Physics, 12, 867-872.
24. OVERGAARD, J., 1987, Hyperthermia as an adjuvant to radiotherapy. Review of the randomized multicenter studies of the European Society for Hyperthermic Oncology. Strahlentherapie und Onkologie, 163, 453-457.
25. OVERGAARD, J., 1989, The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology, and Physics, 16, 535-549.
26. OVERGAARD, J., 1990, The rationale for clinical trials. Practical aspects of clinical hyperthermia, edited by S. B. Field and J. W. Hand (London and Philadelphia: Taylor and Francis), pp. 213-241.
27. OVERGAARD, J., 1995, Thermoradiotherapy of malignant melanoma. Medical Radiology. Thermoradiotherapy and Thermochemotherapy Vol. 2. Clinical Applications edited by M. H. Seegenschmiedt, P. Fessenden and C. Vernon (Berlin: Springer-Veriag), pp. 69-83.
28. OVERGAARD, J., and BACH ANDERSEN, J., 1995, Hyperthermia. Oxford Textbook of Oncology edited by M. Peckham, H. Pinedo and U. Veronesi (Oxford, Oxford University Press), pp. 823-835.
29. OVERGAARD, J., and BENTZEN, S. M., 1990, Radiotherapy alone or combined with hyperthermia in the treatment of advanced malignant melanoma. Pigment Cell. Vol. 10. Therapy of advanced melanoma, edited by P. Rümke (Basel: Karger) pp. 14-35.
30. OVERGAARD, J., GONZALEZ GONZALEZ, D., HUME, S. P., ARCANGELI, G., DAHL, O., MELLA, O., and BENTZEN, S. M., 1995a, Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet, 345, 540-543.
31. OVERGAARD, J., and NIELSEN, O. S., 1983, The importance of thermotolerance for the clinical treatment with hyperthermia. Radiotherapy and Oncology, 1, 167-178.
32. OVERGAARD, J., and OVERGAARD, M., 1987, Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. International Journal of Hyperthermia, 3, 483-501.
33. OVERGAARD, J., VAN DER ZEE, C., VERNON, C., GONZALEZ GONZALEZ, D., and ARCANGELI, G., 1995b, Thermoradiotherapy of malignant tumors. European randomized multicenter trials evaluating the effect of adjuvant hyperthermia in radiotherapy. Progress in Radio-Oncology V, edited by H. D. Kogelnik (Bologna: Monduzzi Editore), pp. 507-513.
34. PEREZ, C. A., GILLESPIE, B., PAJAK, T., HORNBACK, N. B., EMAMI, B. N., and RUBIN, P., 1989, Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group. International Journal of Radiation Oncology, Biology, and Physics, 16, 551-558.
35. PEREZ, C. A., PAJAK, T., EMAMI, B., HORNBACK, N. B., TUPCHONG, L., and RUBIN. P., 1991, Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. American Journal of Clinical Oncology, 14, 133-141.
36. SAPARETO, S. A, 1987, Thermal isoeffect dose: addressing the problem of thermotolerance. International Journal of Hyperthermia, 3, 297-305.
37. SHIDNIA, H., HORNBACK, N. B., SHEN, R. N., SHUPE, R. E., and YUNE, M., 1990, An overview of the role of radiation therapy and hyperthermia in treatment of malignant melanoma. Advances in Experimental Medicine and Biology, 267, 531-545.
38. SNEED, P. K., LARSON, D. A., and GUTIN, P. H., 1994, Brachytherapy and hyperthermia for malignant astrocytomas. Seminars in Oncology, 21, 186-197.
39. VALDAGNI, R., LIU, F.-F., and KAPP, D. S., 1988, Important prognostic factors influencing outcome of combined radiation and hyperthermia. International Journal of Radiation Oncology, Biology, and Physics, 15, 959-972.